Zhang Lab

National University of Singapore

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	5-hydroxytryptamine receptor 2A
Species	Homo sapiens (Human)
Gene	HTR2A
Synonym	5-HT-2 serotonin receptor 2A serotonin 5HT-2 receptor 5-HT-2A 5-HT2A receptor 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled 5Ht-2 'D' receptor [ Show all ]
Disease	Depression Unspecified Diabetes Erythropoietic porphyria Fibromyalgia Sleep disorders Schizophrenia Psychiatric disorder Pancreatitis Mood disorder Migraine Hemorrhoids Glaucoma Central nervous system disease Cardiovascular disorder Addiction Schizophrenia; Sleep maintenance insomnia Alcohol use disorders Anxiety disorder [ Show all ]
Length	471
Amino acid sequence	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV
UniProt	P28223
Protein Data Bank	6a93, 6a94
GPCR-HGmod model	P28223
3D structure model	This structure is from PDB ID 6a93.
BioLiP	BL0441025,BL0441028, BL0441031, BL0441030,BL0441033, BL0441029,BL0441032, BL0441026, BL0441024,BL0441027
Therapeutic Target Database	T32060
ChEMBL	CHEMBL224
IUPHAR	6
DrugBank	BE0000451

Ligand

Name	bromocriptine
Molecular formula	C32H40BrN5O5
IUPAC name	(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
Molecular weight	654.606
Hydrogen bond acceptor	6
Hydrogen bond donor	3
XlogP	3.8
Synonyms	BRD-K14496212-066-04-8 Bromocriptine [BAN] Bromoergocriptine (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman CCRIS 3244 13177-EP2272832A1 dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo 13177-EP2295412A1 Ergocryptine, 2-bromo-(8CI) 13177-EP2311829A1 Lopac0_000171 2-Bromoergocryptine OZVBMTJYIDMWIL-AYFBDAFISA-N 88085-EP2298415A1 SCHEMBL25297 Apo-Bromocriptine BDBM81993 Bromocriptina Bromocriptine+ (GTP-) C32H40BrN5O5 (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman CHEMBL493 13177-EP2280008A2 DSSTox_RID_76692 13177-EP2298731A1 Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-,(5'-alpha)- 13177-EP2316834A1 NCGC00024584-03 22260-51-1 (mesylate (salt)) Parlodel Snaptabs AC-13601 SR-01000075356-5 ZINC53683151 BPBio1_001131 Bromocriptine (USAN/INN) Bromocryptin (+)-Bromocriptine methanesulfonate CB-154 08Y 13177-EP2292614A1 Ergocryptine, 2-bromo- 13177-EP2311808A1 hexahydroindolo[4,3-fg]quinoline-9-carboxamide 2-Bromo-alpha-ergokryptin NCI60_001365 3A64E3G5ZO Prestwick1_000121 AKOS015961273 Bagren Bromergocryptine Bromocriptine [USAN:BAN:INN] Bromoergocryptine (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione CHEBI:3181 13177-EP2275420A1 DSSTox_CID_2687 13177-EP2295413A1 Ergoset 13177-EP2311837A1 LS-64540 2-Bromoergocryptine Methanesulfonate Parlodel 88085-EP2298742A1 SPBio_002101 BIDD:GT0464 Bromocriptina [INN-Spanish] Bromocriptinum Carboprost Methylate,(S) (6aR,9R)-5-bromo-N-((2R,5S,10aS,10bS)- D03165 13177-EP2287165A2 DTXSID1022687 13177-EP2298738A1 Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)- 2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione NCGC00024584-04 25614-03-3 PDSP2_001500 AC1L1KXS Tox21_110907 [2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9- BRD-K14496212-001-01-1 Bromocriptine methanesulfonate Bromocryptine (4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0;{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0;{2,7}.0;{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide CCG-204266 10b-hydroxy-5-isobutyl-2-isopropyl-3,6- DB01200 13177-EP2292620A2 Ergocryptine, 2-bromo- (8CI) 13177-EP2311818A1 J-016067 2-Bromo-alpha-ergokryptine NSC169774 Prestwick2_000121 Alti-Bromocriptine BC206491 Bromocriptin Bromocriptine [USAN:INN:BAN] C06856 (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman 13177-EP2277876A1 DSSTox_GSID_22687 13177-EP2295439A1 Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)- 13177-EP2316470A2 N-[(2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-bromo-methyl-[?]carboxamide 2-Bromoergokryptine Parlodel (TN) 88085-EP2305648A1 SR-01000075356 UNII-3A64E3G5ZO Biomol-NT_000005 Bromocriptinum [INN-Latin] CAS-25614-03-3 (6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide D06YFA 13177-EP2287166A2 EINECS 247-128-5 13177-EP2298779A1 GTPL35 2-Bromo-alpha-ergocryptine NCGC00024584-05 Prestwick0_000121 AC1Q2716 [ Show all ]
Inchi Key	OZVBMTJYIDMWIL-AYFBDAFISA-N
Inchi ID	InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1
PubChem CID	31101
ChEMBL	CHEMBL493
IUPHAR	35
BindingDB	81993
DrugBank	DB01200
Structure SDF download
Lipinski's druglikeness	This ligand is heavier than 500 daltons.

Experimental Data

Parameter	Value	Reference	Database source
	N/A	N/A	DrugBank
Activity	<75.0 %	None	ChEMBL
EC50	1.778 nM	None	ChEMBL
IC50	36.0 nM	DrugMatrix in vitro pharmacology data	ChEMBL
Ki	10.0 nM	DrugMatrix in vitro pharmacology data	ChEMBL
Ki	100.0 nM	PMID12388666	IUPHAR
Ki	107.15 nM	PMID12388666	BindingDB

zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417